Skip to content

Imagine waking up drenched in sweat at 3am, or struggling through a meeting because a hot flush hits out of nowhere. For millions of Aussie women, these are the harsh realities of menopause and perimenopause. But here's the good news: effective treatments exist, and Medicare is stepping up to make them more accessible in 2026. Whether you're navigating hot flushes, mood swings, or vaginal dryness, understanding your options—and what our public health system covers—can transform your midlife experience.

Understanding Menopause in Australia

Menopause marks the end of menstrual cycles, typically around age 51 for Australian women, though perimenopause can start years earlier with fluctuating hormones causing vasomotor symptoms (VMS) like hot flushes and night sweats.Three-quarters of Aussie women experience these symptoms, with over a quarter finding them moderately to severely bothersome. Beyond physical discomfort, menopause impacts sleep, mood, bone health, and quality of life, making informed treatment choices essential.

In Australia, we're seeing real progress. The government is investing in national clinical guidelines for perimenopause and menopause, set for release soon, to ensure consistent, evidence-based care nationwide. Plus, new Medicare Benefits Schedule (MBS) items from 2025-26 offer dedicated health assessments for menopause, backed by $26 million in funding.

Menopausal Hormone Therapy (MHT): The Gold Standard Treatment

MHT, once called HRT, is the most effective treatment for moderate to severe menopausal symptoms, particularly VMS, and offers benefits like improved quality of life, osteoporosis prevention, and potential cardiovascular protection. It's most beneficial for women under 60 or within 10 years of menopause.

Types of MHT Available in Australia

Aussie doctors tailor MHT based on your health history and whether you have a uterus:

  • Oestrogen-only MHT: For women post-hysterectomy, as it avoids endometrial risks.
  • Combined oestrogen plus progestogen:
    • Cyclic: Progestogen added 12-14 days per month—ideal for perimenopause.
    • Continuous combined: Daily for postmenopausal women.
  • Delivery methods: Pills, patches, gels, vaginal creams, or IUDs—your doctor will help find the best fit.
  • Other options: Tibolone for libido and bone health; testosterone (e.g., Androfeme) for hypoactive sexual desire disorder, with strong 2024 evidence from Melbourne's IMS Congress.

Progestogens like micronised progesterone are body-identical and safe in fixed-dose combinations. There's no set maximum duration—many women continue long-term after weighing risks and benefits.

Who Should Consider MHT?

Healthy women with bothersome symptoms and no contraindications (e.g., breast cancer history) benefit most. Always discuss personalised risks—like a small increase in breast cancer with long-term use—with your GP.

Non-Hormonal Treatment Options

Not everyone suits MHT, so alternatives exist:

  • Medications: SSRIs/SNRIs, gabapentin, or oxybutynin for VMS—moderate effect but side effects limit use.
  • Oestrogen plus SERM (e.g., bazedoxifene): Tablet for hot flushes and osteoporosis prevention; suitable for women with a uterus, fewer side effects than standard MHT.
  • Vaginal oestrogen: Safe long-term for genitourinary symptoms like dryness; low-dose, any age.
  • Lifestyle and therapies: Cognitive behavioural therapy (CBT), pelvic floor training, hypnosis for sleep.

Natural and Complementary Therapies

Many Aussies try herbal options like black cohosh, red clover, or Promensil, but trials show limited benefit and purity concerns due to lax regulation. Yoga, mindfulness, acupuncture, and nutrition can support wellbeing, but they're not substitutes for evidence-based treatments.

What Medicare Covers for Menopause Treatment in 2026

Medicare makes menopause care more affordable. Standard GP consultations and telehealth are rebated, as are PBS-subsidised MHT medications. From 2025-26:

  • New MBS health assessments specifically for menopause/perimenopause ($26 million investment).
  • Expanded endometriosis clinics for menopause support.
  • Ongoing PBS investments, including potential for more body-identical MHT listings to lower costs.

Check the PBS website for subsidised items—many MHT formulations qualify, reducing out-of-pocket costs significantly. Mental health services via Medicare are also available for mood impacts. Note: Private health extras may cover allied therapies like physiotherapy.

Practical Tips for Managing Menopause

  1. Book a GP visit for a menopause health assessment—use the new MBS item if eligible.
  2. Track symptoms in a diary to guide treatment discussions.
  3. Layer clothing, stay hydrated, and try cooling techniques for hot flushes.
  4. Incorporate weight-bearing exercise for bone health and yoga for stress.
  5. If stopping MHT, taper gradually; symptoms may return in 40% of women over 60.
  6. Explore Jean Hailes or Australasian Menopause Society resources for free tools.

Disclaimer: This isn't medical advice—always consult a healthcare professional for personalised guidance.

Your Next Steps for Menopause Relief

Don't suffer in silence—start with your GP for a full check-up and explore MHT or alternatives. Leverage Medicare's expanded support, track your symptoms, and connect with resources like Jean Hailes. With the right plan, you can reclaim your energy, sleep, and confidence. You're not alone; Aussie women are getting the backing we deserve in 2026.

Frequently Asked Questions

Benefits generally outweigh risks if started earlier, but individual assessment is key. Low-dose vaginal options are safe long-term.[3]
Not routinely on PBS for menopause, but GP consultations are rebated. Check eligibility for hypoactive sexual desire.[1]
Limited evidence supports them; they're unregulated. Discuss with your doctor to avoid interactions.[1]
From 2025-26, ask your GP about temporary MBS items. It's funded for two years initially.[4]
Non-hormonal meds, CBT, or lifestyle changes work well. Vaginal oestrogen helps genitourinary issues without systemic risks.[5]
Possibly—over 40% of women 60-65 have persistent VMS. Taper slowly and monitor.[3]
Share:

Related Articles

Comments (0)

Log in or sign up to leave a comment.

No comments yet. Be the first to share your thoughts!